NDC 78714-001

FLUDEOXYGLUCOSE F-18

Fludeoxyglucose F-18

FLUDEOXYGLUCOSE F-18 is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Barbara Ann Karmanos Cancer Hospital. The primary component is Fludeoxyglucose F-18.

Product ID78714-001_5902c209-4d0a-437b-aa43-b3bd72c784ea
NDC78714-001
Product TypeHuman Prescription Drug
Proprietary NameFLUDEOXYGLUCOSE F-18
Generic NameFludeoxyglucose F-18
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-01-31
Marketing CategoryANDA / ANDA
Application NumberANDA204385
Labeler NameBarbara Ann Karmanos Cancer Hospital
Substance NameFLUDEOXYGLUCOSE F-18
Active Ingredient Strength300 mCi/mL
Pharm ClassesRadioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 78714-001-30

30 mL in 1 VIAL, GLASS (78714-001-30)
Marketing Start Date2020-01-31
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "FLUDEOXYGLUCOSE F-18" or generic name "Fludeoxyglucose F-18"

NDCBrand NameGeneric Name
11994-015Fludeoxyglucose F-18Fludeoxyglucose F-18
16129-001Fludeoxyglucose F-18Fludeoxyglucose F-18
24450-647FLUDEOXYGLUCOSE F-18FLUDEOXYGLUCOSE F-18
24468-001Fludeoxyglucose F-18Fludeoxyglucose F-18 Injection
40098-101Fludeoxyglucose F-18Fludeoxyglucose F-18
52768-001Fludeoxyglucose F-18Fludeoxyglucose F-18
65857-150Fludeoxyglucose F-18Fludeoxyglucose F-18
70681-002Fludeoxyglucose F-18Fludeoxyglucose F-18
78714-001FLUDEOXYGLUCOSE F-18FLUDEOXYGLUCOSE F-18
24562-001FludeoxyglucoseFludeoxyglucose F-18
24417-001FLUDEOXYGLUCOSE F 18FLUDEOXYGLUCOSE F-18
29998-001Fludeoxyglucose F 18Fludeoxyglucose F-18
49609-101Fludeoxyglucose F 18Fludeoxyglucose F-18
52670-551Fludeoxyglucose F 18Fludeoxyglucose F-18
60055-334Fludeoxyglucose F 18Fludeoxyglucose F-18
24562-003Fludeoxyglucose F18Fludeoxyglucose F-18
44338-001Fludeoxyglucose F18Fludeoxyglucose F-18
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.